Suppr超能文献

两种低剂量口服避孕药对激素和代谢参数影响的随机交叉比较:I. 对性激素水平的影响

A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.

作者信息

Kuhl H, Gahn G, Romberg G, März W, Taubert H D

出版信息

Contraception. 1985 Jun;31(6):583-93. doi: 10.1016/0010-7824(85)90058-7.

Abstract

The effect of a low-dose triphasic oral contraceptive (OC) containing ethinyl estradiol and levonorgestrel (EE/NG) upon serum levels of endogenous sexual hormones was compared to that of a preparation containing EE and desogestrel (EE/DG). Blood samples were taken on Day 6, 11, 21, and 28 of a control cycle and of the third cycle of treatment with either the EE/NG or EE/DG preparation (11 volunteers each). After a washout period of 3 months, the contraceptives were changed in a cross-over fashion. Blood samples were again taken on Day 6, 11, 21, and 28 of the third washout cycle and the third treatment cycle. There was no significant suppression of serum LH and FSH during treatment with EE/NG and EE/DG except on Day 21, while estradiol levels were significantly lowered. Similar to the gonadotropin concentrations, the estrogen levels showed great individual variations; although they were depressed in the majority of the women, there was a considerable stimulation of follicular activity in 36% of the women under EE/NG and 18% under EE/DG. Both EE/NG and EE/DG suppressed significantly serum progesterone, testosterone, and DHEA-S, while prolactin was unaffected. In three cases an escape ovulation seemed to have occurred, but no pregnancy was observed. The spottings (8/22 women) and breakthrough bleedings (6/22 women) did not correlate with the serum levels of estradiol. The results indicate that the suppression of gonadotropin secretion during treatment with low-dose OC is a time-dependent process which in some women may be at or below the threshold of safe ovulation inhibition.

摘要

将含有炔雌醇和左炔诺孕酮(EE/NG)的低剂量三相口服避孕药(OC)对血清内源性性激素水平的影响与含有炔雌醇和去氧孕烯(EE/DG)的制剂进行了比较。在对照周期以及使用EE/NG或EE/DG制剂治疗的第三个周期的第6、11、21和28天采集血样(每组11名志愿者)。经过3个月的洗脱期后,以交叉方式更换避孕药。在第三个洗脱周期和第三个治疗周期的第6、11、21和28天再次采集血样。在用EE/NG和EE/DG治疗期间,除第21天外,血清促黄体生成素(LH)和促卵泡生成素(FSH)没有受到显著抑制,而雌二醇水平显著降低。与促性腺激素浓度相似,雌激素水平也存在很大的个体差异;虽然大多数女性的雌激素水平降低,但在使用EE/NG的女性中有36%、使用EE/DG的女性中有18%出现了相当程度的卵泡活性刺激。EE/NG和EE/DG均显著抑制血清孕酮、睾酮和硫酸脱氢表雄酮(DHEA-S),而催乳素未受影响。有3例似乎发生了突破性排卵,但未观察到妊娠。点滴出血(8/22名女性)和突破性出血(6/22名女性)与血清雌二醇水平无关。结果表明,低剂量OC治疗期间促性腺激素分泌的抑制是一个时间依赖性过程,在一些女性中可能处于或低于安全抑制排卵的阈值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验